Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker

BACKGROUND: The aim was to compare the effect of etanercept (ETN) and conventional synthetic disease-modifying anti-rheumatic drug (DMARD) therapy on serum amyloid A (SAA) levels and to determine whether SAA reflects rheumatoid arthritis (RA) disease activity better than C-reactive protein (CRP). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yong Gil, Balasubramani, Goundappa K., Metes, Ilinca D., Levesque, Marc C., Bridges, S. Louis, Moreland, Larry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869396/
https://www.ncbi.nlm.nih.gov/pubmed/27188329
http://dx.doi.org/10.1186/s13075-016-1009-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869396/
https://www.ncbi.nlm.nih.gov/pubmed/27188329
http://dx.doi.org/10.1186/s13075-016-1009-y

Ejemplares similares